Misbah Tahir's most recent trade in IGM Biosciences Inc was a trade of 1,522 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 Jun 2025 | 1,522 | 178,802 (0%) | 0% | 1.2 | 1,825 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 14 Mar 2025 | 7,329 | 180,324 (0%) | 0% | 1.2 | 9,015 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 16 Dec 2024 | 1,708 | 187,653 (0%) | 0% | 7.5 | 12,776 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2024 | 66,667 | 189,361 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 13 Sep 2024 | 1,487 | 122,694 (0%) | 0% | 11.5 | 17,158 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Jul 2024 | 55,000 | 0 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Jul 2024 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 33,111 | 121,959 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 2,222 | 124,181 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 14 Jun 2024 | 1,570 | 88,848 (0%) | 0% | 7.6 | 11,893 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.88 per share. | 13 Mar 2024 | 2,897 | 92,961 (0%) | 0% | 9.9 | 28,608 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.17 per share. | 13 Mar 2024 | 2,543 | 90,418 (0%) | 0% | 10.2 | 25,864 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 92,500 | 92,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 46,250 | 95,858 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 23 May 2023 | 1,244 | 50,726 (0%) | 0% | 12.3 | 15,302 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 11.71 per share. | 23 May 2023 | 398 | 51,970 (0%) | 0% | 11.7 | 4,661 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 23 May 2023 | 15 | 50,711 (0%) | 0% | 13 | 195 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 52,500 | 52,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 26,250 | 51,572 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.73 per share. | 14 Mar 2023 | 1,768 | 25,322 (0%) | 0% | 18.7 | 33,118 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 16 Dec 2022 | 3,801 | 27,090 (0%) | 0% | 20 | 76,020 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.77 per share. | 16 Dec 2022 | 1,468 | 31,706 (0%) | 0% | 18.8 | 27,561 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.36 per share. | 16 Dec 2022 | 815 | 30,891 (0%) | 0% | 19.4 | 15,778 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 23 Nov 2022 | 600 | 33,451 (0%) | 0% | 21.4 | 12,826 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 12.84 per share. | 23 Nov 2022 | 353 | 34,051 (0%) | 0% | 12.8 | 4,533 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.99 per share. | 23 Nov 2022 | 277 | 33,174 (0%) | 0% | 22.0 | 6,092 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.10 per share. | 26 May 2022 | 950 | 33,698 (0%) | 0% | 17.1 | 16,247 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 12.38 per share. | 13 May 2022 | 391 | 34,648 (0%) | 0% | 12.4 | 4,841 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 6,084 | 34,257 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 12,500 | 28,173 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 50.99 per share. | 15 Nov 2021 | 86 | 5,673 (0%) | 0% | 51.0 | 4,385 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 45.91 per share. | 14 May 2021 | 45 | 5,587 (0%) | 0% | 45.9 | 2,066 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 2,750 | 120,097 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 05 Mar 2021 | 2,750 | 5,542 (0%) | 0% | 1.4 | 3,823 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 2,750 | 122,847 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 21 Dec 2020 | 2,750 | 2,792 (0%) | 0% | 1.4 | 3,823 | Common Stock |
| IGM Biosciences Inc | Misbah Tahir | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 45.45 per share. | 13 Nov 2020 | 42 | 42 (0%) | 0% | 45.5 | 1,909 | Common Stock |